Transgenic rescue of defective Cd36 enhances myocardial adenylyl cyclase signaling in spontaneously hypertensive rats

[1]  J. Nerbonne,et al.  CD36 Protein Influences Myocardial Ca2+ Homeostasis and Phospholipid Metabolism , 2012, The Journal of Biological Chemistry.

[2]  P. Stopka,et al.  Role of complement regulatory proteins CD46, CD55 and CD59 in reproduction , 2012, Folia Zoologica.

[3]  M. Pravenec,et al.  Role of FAT/CD36 in novel PKC isoform activation in heart of spontaneously hypertensive rats , 2011, Molecular and Cellular Biochemistry.

[4]  H. Watkins,et al.  Common variation in the CD36 (fatty acid translocase) gene is associated with left-ventricular mass , 2011, Journal of hypertension.

[5]  J. Dyck,et al.  Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction , 2011, Journal of Molecular Medicine.

[6]  K. Naseem,et al.  Thrombospondin-1 induces platelet activation through CD36-dependent inhibition of the cAMP/protein kinase A signaling cascade. , 2010, Blood.

[7]  A. Tichopád,et al.  Gene expression profiling of sex differences in HIF1-dependent adaptive cardiac responses to chronic hypoxia. , 2010, Journal of applied physiology.

[8]  Yanjie Lu,et al.  Propranolol regulates cardiac transient outward potassium channel in rat myocardium via cAMP/PKA after short-term but not after long-term ischemia , 2010, Naunyn-Schmiedeberg's Archives of Pharmacology.

[9]  P. Pagliaro,et al.  Effects of a protocol of ischemic postconditioning and/or captopril in hearts of normotensive and hypertensive rats , 2010, Basic Research in Cardiology.

[10]  Chaoqian Xu,et al.  MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. , 2009, Cardiovascular research.

[11]  T. Eschenhagen,et al.  β-Adrenergic stimulation and myocardial function in the failing heart , 2009, Heart Failure Reviews.

[12]  T. Xanthos,et al.  The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation. , 2009, European journal of pharmacology.

[13]  R. Kloner,et al.  Ischemic preconditioning maintains cardioprotection in aging normotensive and spontaneously hypertensive rats , 2009, Experimental Gerontology.

[14]  Jin Zhang,et al.  Dynamic Protein Kinase A Activities Induced by β-Adrenoceptors Dictate Signaling Propagation for Substrate Phosphorylation and Myocyte Contraction , 2009, Circulation research.

[15]  M. Zaccolo,et al.  Protein Kinase A Type I and Type II Define Distinct Intracellular Signaling Compartments , 2008, Circulation research.

[16]  Reiko Kurotani,et al.  Disruption of Type 5 Adenylyl Cyclase Enhances Desensitization of Cyclic Adenosine Monophosphate Signal and Increases Akt Signal With Chronic Catecholamine Stress , 2007, Circulation.

[17]  M. Zaccolo,et al.  Compartmentalized cAMP/PKA signalling regulates cardiac excitation–contraction coupling , 2006, Journal of Muscle Research & Cell Motility.

[18]  P. Clopton,et al.  Increased Cardiac Adenylyl Cyclase Expression Is Associated With Increased Survival After Myocardial Infarction , 2006, Circulation.

[19]  E. Lakatta,et al.  Subtype-specific α1- and β-adrenoceptor signaling in the heart , 2006 .

[20]  G. Lopaschuk,et al.  Fatty Acid Translocase/CD36 Deficiency Does Not Energetically or Functionally Compromise Hearts Before or After Ischemia , 2004, Circulation.

[21]  J. Auman,et al.  Ontogenesis of β-Adrenoceptor Signaling: Implications for Perinatal Physiology and for Fetal Effects of Tocolytic Drugs , 2003, Journal of Pharmacology and Experimental Therapeutics.

[22]  B. Kobilka,et al.  Myocyte Adrenoceptor Signaling Pathways , 2003, Science.

[23]  William Jou,et al.  Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  H. Girouard,et al.  Chronic antioxidant treatment improves sympathetic functions and β-adrenergic pathway in the spontaneously hypertensive rats , 2003, Journal of hypertension.

[25]  E. Olson,et al.  Dilated Cardiomyopathy and Sudden Death Resulting From Constitutive Activation of Protein Kinase A , 2001, Circulation research.

[26]  B. Kobilka,et al.  β-Adrenergic Receptor Subtype-Specific Signaling in Cardiac Myocytes from β1 and β2 Adrenoceptor Knockout Mice , 2001 .

[27]  T. Kurtz,et al.  Defective Fatty Acid Uptake in the Spontaneously Hypertensive Rat Is a Primary Determinant of Altered Glucose Metabolism, Hyperinsulinemia, and Myocardial Hypertrophy* , 2001, The Journal of Biological Chemistry.

[28]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[29]  B. Kobilka,et al.  Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  F. Leenen,et al.  Mortality After Coronary Artery Occlusion in Different Models of Cardiac Hypertrophy in Rats , 2001, Hypertension.

[31]  T. Kurtz,et al.  Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats , 2001, Nature Genetics.

[32]  G. Dorn,et al.  Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. , 2000, Circulation.

[33]  M. Lohse,et al.  Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[34]  J. Flint,et al.  Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats , 1997, Nature Genetics.

[35]  M. Böhm,et al.  Heterotrimeric G proteins in heart disease. , 1996, Cellular signalling.

[36]  H. Kato,et al.  Adrenoceptors in SHR: alterations in binding characteristics and intracellular signal transduction pathways. , 1995, Life sciences.

[37]  M. Spence,et al.  Mapping of quantitative trait loci for blood pressure and cardiac mass in the rat by genome scanning of recombinant inbred strains. , 1995, The Journal of clinical investigation.

[38]  M. Ohyanagi,et al.  Intracellular distribution of cardiac beta-adrenoceptors in SHR and WKY. , 1989, Japanese circulation journal.

[39]  M. Anand-Srivastava.  Altered responsiveness of adenylate cyclase to adenosine and other agents in the myocardial sarcolemma and aorta of spontaneously-hypertensive rats. , 1988, Biochemical pharmacology.

[40]  J. Seidman,et al.  CD36 overexpression predisposes to arrhythmias but reduces infarct size in spontaneously hypertensive rats: gene expression profile analysis. , 2012, Physiological genomics.

[41]  D. Bernstein,et al.  THE ROLE OF β-ADRENERGIC RECEPTORS IN HEART FAILURE: DIFFERENTIAL REGULATION OF CARDIOTOXICITY AND CARDIOPROTECTION. , 2011, Progress in pediatric cardiology.

[42]  O. Pechanova,et al.  Impaired cardiac ischemic tolerance in spontaneously hypertensive rats is attenuated by adaptation to chronic and acute stress. , 2011, Experimental and clinical cardiology.

[43]  A. Firth,et al.  Adenylyl Cyclase Type 6 Deletion Decreases Left Ventricular Function via Impaired Calcium Handling , 2008, Circulation.

[44]  R. Stopkova,et al.  Real time RT-PCR with a newly designed set of primers confirmed the presence of 2b and 2x/d myosin heavy chain mRNAs in the rat slow soleus muscle. , 2008, Physiological research.

[45]  B. Kobilka,et al.  Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice. , 2001, Molecular pharmacology.